Skip to main content
Full access
Influential Publications
Published Online: 15 April 2015

Updates on the Prevalence of Body Dysmorphic Disorder: A Population-Based Survey

Abstract

Body dysmorphic disorder (BDD) is characterised by a preoccupation with perceived defects in one’s appearance, which leads to significant distress and/or impairment. Although several studies have investigated the prevalence of BDD, many studies have methodological limitations (e.g., small sample sizes and student populations), and studies on the prevalence of BDD in the general population are limited. In the current study, 2510 individuals participated in a representative German nationwide survey. Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria for BDD and associated characteristics such as suicidality and the prevalence of plastic surgeries were examined using self-report questionnaires. The prevalence of current BDD was 1.8% (N = 45). Further, individuals with BDD, relative to individuals without BDD, reported significantly more often a history of cosmetic surgery (15.6% vs. 3.0%), higher rates of suicidal ideation (31.0% vs. 3.5%) and suicide attempts due to appearance concerns (22.2% vs. 2.1%). The current findings are consistent with previous findings, indicating that self-reported BDD is a common disorder associated with significant morbidity.
Reprinted with permission from Psychiatry Research 2010; 178:171–175

1. Introduction

Individuals with body dysmorphic disorder (BDD) are distressed about perceived flaws in their physical appearance, commonly in their face (e.g., wrinkles, size or shape of the nose or ears; American Psychiatric Association [APA], 2000). Although these “defects” are usually not noticeable to others, individuals with BDD misperceive their body part(s) of concern as unattractive and repulsive and often spend several hours per day worrying about their appearance. They frequently engage in time-consuming repetitive behaviours such as comparing, mirror checking, camouflaging, excessive grooming or reassurance seeking (e.g., Phillips et al., 1993; Phillips, 1991). Further, BDD is associated with significant morbidity, including social or occupational impairment, being housebound, hospitalisation and suicide attempts (e.g., Phillips and Menard, 2006; Phillips et al., 1993).
Despite increased awareness of BDD in the last decade, it is a relatively unknown and under-studied disorder. Although some studies have examined the prevalence of BDD, the obtained rates vary widely, which may be due to methodological differences and limitations (e.g., nonrepresentative populations and small sample sizes). Studies examining prevalence rates in student populations, in which higher base rates might be expected, have obtained prevalence rates of self-reported BDD ranging from 5% (Cansever et al., 2003, N = 420 female nursing school students; Bohne et al., 2002, N = 133 psychology students;) to 13% (Biby, 1998, N = 102 psychology students). A few studies examined the prevalence of BDD using structured clinical interviews (Otto et al., 2001; Bienvenu et al., 2000; Faravelli et al., 1997). Specifically, Otto et al. (2001) reported a BDD prevalence rate of 0.7% in a sample of 658 nondepressed and 318 depressed women between 36 and 44 years of age. Faravelli and colleagues examined the prevalence of BDD in 637 subjects from the general population of Tuscany (Italy) and also obtained a prevalence of 0.7% (Faravelli et al., 1997). In addition, Bienvenu et al. (2000) found a BDD prevalence of 3% in a small community sample (N = 73). Taken together, these results suggest that BDD prevalence rates vary significantly depending on the subject population, sample size and assessment methods.
To our knowledge, only two studies have been conducted on the prevalence of BDD using a representative sample (N > 2,000) of the general population. Rief et al. (2006) conducted a survey study in 2004 with 2552 participants selected by an independent agency that divided Germany into 258 sample point regions (the sample point regions were derived from representative data of the last federal elections). The prevalence of current BDD was 1.7% (N = 42). Moreover, consistent with previous research emphasising the morbidity associated with BDD (e.g., Phillips and Menard, 2006), individuals with BDD reported significantly higher rates of appearance-related suicidal ideation (19% vs. 3%) and suicide attempts (7% vs. 1%) than did individuals without BDD. Individuals with BDD also reported significantly higher rates of cosmetic surgeries than did those without BDD (7.2% vs. 2.8%). In addition, 27% of males and 41% of females without BDD reported being preoccupied with the appearance of at least one body part (though not meeting Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria for BDD), suggesting that body dissatisfaction is a common phenomenon in the general population (Rief et al., 2006). Further, Koran et al. (2008) conducted a national household telephone survey in 2004 with 2513 participants, of whom 2048 participants qualified for a more detailed BDD screening, based on their initial responses. They obtained an estimated point prevalence of 2.4% (N = 49), which is comparable to the one obtained by Rief et al., further stressing that BDD is a common psychiatric disorder.
In the absence of large replication studies, the stability of previous findings remains unknown. Hence, in the current study, we sought to replicate previous findings (Koran et al., 2008; Rief et al., 2006) using another large, representative, nation-wide community sample. Specifically, we investigated the prevalence of BDD, associated features of BDD, such as suicidality or a history of cosmetic surgery, and rates of preoccupation with single body parts in the general population.

2. Materials and methods

2.1. Subjects

The sample consisted of 2510 participants from the general German population (51.6% females), ranging from 14 to 93 years of age (mean 46.9; S.D. 18.4). Approximately 57.8% were married, 0.8% were separated, 26% were single, 7.5% were divorced and 7.9% were widowed.

2.2. Subject Selection

As in our previous study (Rief et al., 2006), an independent agency (USUMA, Berlin) divided Germany into 258 sample point regions, which were derived from representative data from the last federal elections. The selection process included the following steps: First, one of the sample point regions was randomly selected. Then, an address was selected following a random route procedure, and one of the household members of this address was selected by chance (“Sweden procedure”). The study staff then made three attempts to contact the selected household member at their address (face-to-face). Subjects had to be 14 years of age or older to be included in this selection process. The data collection took place between May and June 2007. Initially, 4205 individuals were contacted according to the procedure described above, and 61.9% of those initially contacted participated in this survey. Of the 38.1% targeted individuals who did not participate, 9.7% were not included because after three consecutive attempts, we were still unable to reach any member of their selected household, 3.9% of the targets were not included because we were unable to reach them after three consecutive attempts, 13.8% were not included because the household refused participation and 8.6% were not included because they themselves refused participation. The success and refusal rates are very similar to the ones obtained in previous national health surveys in Germany (e.g., Rief et al., 2001, 2006).

2.3. Procedure

The study protocol was approved by the institutional review committee at the German Psychological Association. All participants were tested individually (face to face). Each participant signed an informed consent sheet after the study procedure had been fully explained (in the case of minors, informed consent was additionally obtained from the parents). Afterwards, participants completed the following self-report scales: a) questionnaire assessing DSM criteria for current BDD (see Table 1), and b) a questionnaire assessing clinical characteristics of BDD, such as body parts of concern (e.g., hair, skin, nose and mouth), history of cosmetic surgeries and suicidality due to appearance concerns.
Table 1 DSM-IV Criteria for Body Dysmorphic Disorder.
DSM-IV inclusion rulesDescription of DSM-IV criteria (DSM-IV TR)Item
Agreement to DSM-IV A criterion
Preoccupation with an imagined defect in appearance. If a slight physical anomaly is present, the person’s concern is markedly excessive.
Do you think you have one or more unattractive or disfiguring defects in your appearance, although other people do not share your opinion or believe your concern to be markedly exaggerated? Do you think about your appearance concerns for at least one hour a day?
Either agreement to DSM-IV B1 criterion…
The preoccupation causes clinically significant distress …
If yes, is this defect very distressing to you?
…or agreement to DSM B2 criterion
… or impairment in social, occupational, or other important areas of functioning.
Do the worries about your physical defect cause significant impairment in your everyday life (e.g., in your job or social life)?
Disagreement to DSM-IV C criterionThe preoccupation is not better accounted for by another mental disorder (e.g., dissatisfaction with body shape and size in anorexia nervosa)a. Are you primarily concerned about not being thin enough or becoming too fat?
b. In the last 3 months, have you often restrained from eating for 24 h or longer?
c. In the last 3 months, have you often made yourself vomit after eating something?
d. In the last 3 months, have you often taken more than twice the recommended amount of diuretics?
Notes. If the individual was primarily concerned with his/her weight (Criterion C, item a), questions b–d had to be answered with “no”. It should be noted that the exclusion of primary weight concerns could have led to an underestimation of the BDD prevalence.

2.4. Statistical Analyses

The data were analysed using Bonferroni-corrected two-tailed t-tests and chi square tests. Base rates for the BDD were assessed according to DSM-IV criteria (Table 2). Moreover, to exclude individuals with possible eating disorders (criterion C), we excluded individuals who reported both their body weight as the main focus of concern as well as having one of the following symptoms in the past 3 months: repeatedly fasting for at least 24 h, repeatedly making oneself vomit after eating meals or repeatedly taking more than twice the recommended amount of diuretics.1
Table 2 Base Rates for DSM-IV Criteria for Body Dysmorphic Disorder.
DSM-IV criteriaMales (N = 1142)Females (N = 1368)Chi2 (df = 1)
Do you think you have one or more unattractive or disfiguring defects in your appearance, although other people do not share your opinion or believe your concern to be markedly exaggerated? Do you think about your appearance concerns for at least 1 h a day?
5.3% (61)
14.8% (203)
66.4**
B1. If yes, is this very distressing to you? (ref. to total N = 264)
37.7% (23)
35.5% (72)
1.0
B2. Does this cause significant impairment in your everyday life (e.g., in your job or social life)? (ref. to total N = 264)
34.4% (21)
16.3% (33)
9.7*
Criteria A and B fulfilled (ref. to total N = 2510)
2.5% (29)
5.6% (77)
14.7**
All criteria (A, B, and C) for BDD met
1.5% (17)
2.0% (28)
1.1
Overall Prevalence of BDD


1.8% (N = 45)
Notes. BDD = body dysmorphic disorder; The significance level was set to P<0.01 with a Bonferroni correction for multiple comparisons, 0.05/5; * P<0.01; ** P<0.001; the exact numbers are in parentheses and vary due to some missing values.

3. Results

3.1. Appearance Concerns in the General Population

Overall, 35.3% of the general German population (26.7% males, 42.2% females) reported being concerned about at least one body part. Body parts of concern differed between men and women (Table 3). Specifically, relative to men, women were significantly more often dissatisfied with their breasts, hands, hips/buttocks, legs, skin, stomach and weight, whereas men were slightly more often dissatisfied with their overall muscle build, although it failed to reach statistical significance.
Table 3 Gender Differences Regarding Body Parts of Concern in the General Population (N = 2510).
Body part of concernMales N = 1142Females N = 1368Chi2 (df = 1)
Breast, chest
1.5% (17)
11.0% (151)
90.9*
Ears
2.4% (27)
1.4% (19)
3.3
Ethnic features
0.1% (1)
0.0% (0)
1.2
Eyes
1.1% (12)
1.5% (20)
0.8
Feet
0.4% (5)
0.6% (8)
0.3
Genitals
1.1% (12)
0.7% (9)
1.2
Hair
8.1% (92)
7.4% (101)
0.4
Hands
1.1% (12)
3.1% (42)
12.1*
Hips/buttocks
3.7% (42)
24.3% (332)
208.1*
Legs/knee/thighs
0.5% (6)
2.4% (33)
14.5*
Mouth
0.4% (5)
1.3% (18)
5.3
Muscle build
3.1% (35)
1.3% (18)
9.2+
Nose
4.2% (48)
5.1% (70)
1.2
Primary weight concern
10.9% (125)
22.4% (306)
57.2*
Skin
4.1% (47)
7.4% (101)
12.0*
Stomach
15.6% (178)
24.8% (339)
32.2*
Other
0.8% (9)
1.3% (18)
1.6
Notes. The significance level was set to P<0.003 with a Bonferroni correction for multiple comparisons, 0.05/16; * P<0.003; + P = 0.003; participants were allowed to report more than one appearance concern; the exact numbers are in parentheses.
Base rates for DSM-IV BDD criteria are presented in Table 2. The presence of criterion A preoccupation with an imagined or slight body flaw was significantly higher in females than males. Specifically, 14.8% of the female general population and 5.3% of the male general population reported (a) having one or more unattractive body parts, despite acknowledging that their “flaws” were likely not perceived as such by others, as well as (b) thinking about their perceived flaws for at least 1 hour per day. It should be noted that in order to be included in the BDD group, individuals had to have some appearance concerns other than weight. When taking all DSM criteria into account, the prevalence for current BDD was 1.8% (N = 45), with slightly higher rates for females (2.0%, N = 28) than for males (1.5%, N = 17).

3.2. Associated Features of BDD

The BDD group reported significantly higher rates of cosmetic surgery than did the non-BDD group (15.6% vs. 3.0%; Table 4). As expected, the BDD group also reported significantly more suicidal ideation (31.0% vs. 3.5%) and suicide attempts (22.2% vs. 2.1%) due to appearance concerns, relative to the group without BDD.
Table 4 Associated Features of Individuals With and Without Body Dysmorphic Disorder.
 Individuals with BDD N = 45Individuals without BDD N = 2,465Statistics (Chi2 if not otherwise specified)
Age (years)
M = 48.9 (S.D. = 19.1)
M = 48.0 (S.D. = 17.8)
t(2508) = 0.36
Gender (% females)
62.2% (28)
54.4% (1340)
1.1
Marital status  4.9
 Married42.2% (19)52.4% (1292) 
 Separated0.0% (0)1.3% (32) 
 Divorced17.8% (8)10.5% (259) 
 Widowed15.6% (7)10.3% (253) 
 Single
24.4% (11)
25.5% (629)

Mean income of household below 1250 Euros
24.4% (11)
22.2% (547)
0.1
Unemployed+
13.3% (6)
6.7% (164)
3.1
Focus of appearance concern(s)   
 Breast/chest22.2% (10)6.4% (158)17.7*
 Ears11.1% (5)1.7% (41)21.9*
 Ethnic features0.0% (0)0.0% (1)0.0
 Eyes2.2% (1)1.3% (31)0.3
 Feet4.4% (2)0.4% (11)13.7*
 Genitals4.4% (2)0.8% (19)7.2
 Hair15.6% (7)7.5% (186)4.0
 Hands6.7% (3)2.1% (51)4.4
 Hips/buttocks33.3% (15)14.6% (359)12.3*
 Legs/knees/thighs2.2% (1)1.5% (38)0.1
 Mouth8.9% (4)0.8% (19)32.1*
 Muscle build2.2% (1)2.1% (52)0.0
 Nose15.6% (7)4.5% (111)12.1
 Skin33.3% (15)5.4% (133)62.2*
 Stomach42.2% (19)20.2% (498)13.1*
 Other
8.9% (4)
0.9% (23)
26.3*
Primary concern weight-related

17.5% (431)

Plastic surgery   
 Underwent cosmetic surgery
15.6% (7)
3.0% (74)
125.6*
Suicidality   
 Thoughts about committing suicide due to appearance concerns31.0% (14)3.5% (89)168.0*
 Suicide attempts due to appearance concerns
22.2% (10)
2.1% (50)
127.4*
Notes. BDD = body dysmorphic disorder; the significance level was set to P<0.002 with a Bonferroni correction for multiple comparisons, 0.05/25; * P<0.002; + controlled for years of age and education; participants were allowed to report more than one appearance concern; primary weight concerns were an exclusion criterion in the BDD group in order to exclude possible eating disorders; the exact numbers are in parentheses.

4. Discussion

To our knowledge, this is the third study reporting a nation-wide prevalence rate of BDD using a representative sample of the general population. Because of the great variability in BDD prevalence rates obtained from research with smaller samples, we aimed to replicate recent findings of two nation-wide studies on the prevalence and associated features of BDD (Koran et al., 2008; Rief et al., 2006). The prevalence rate in our current study (1.8%) was very similar to the one obtained in our previous study (1.7%), and to the one obtained by Koran et al. (2.4%). Both suicidal ideation and suicide attempts were quite common in the BDD sample and, as expected, significantly higher in those with, than in those without. The rates of associated features of BDD such as suicidal ideation and particularly suicide attempts due to appearance concerns were somewhat higher than those from our previous study (Rief et al., 2006). Further, after controlling for years of age and education, individuals with BDD were not more often unemployed than individuals without BDD. This finding is inconsistent with previous studies obtaining high rates of unemployment in BDD (e.g., Phillips, 2000). It should be noted though that this is one of the first studies examining BDD and its hallmarks in the general population, rather than in a psychiatric setting. Thus, future research needs to explore this further. Moreover, although we obtained comparable rates of cosmetic surgeries in the non-BDD groups from the current (3.0%) and previous studies (2.8%; Rief et al., 2006), the rate of cosmetic surgery in the BDD groups was somewhat higher in our current study (15.6%) than in our previous study (7.2%). Although it is premature to draw any conclusions from this finding, it is possible that cosmetic surgeries have become more acceptable overall in the last few years, which – in turn – may have influenced people with appearance concerns in their decision-making process.
Analysis of the specific body parts of concern within the BDD group revealed that the most frequently disliked body parts were the stomach, hips/buttocks, skin and breast/chest, whereas individuals without BDD mostly reported body image concerns related to their weight, stomach and hips/buttocks. Recall that primary weight concerns were an exclusion criterion within the BDD group. Consequently, it is not possible to directly compare weight concerns between the two groups.
Our current findings provide further evidence that BDD is a common disorder (1.8%) in the general population, and that it is associated with significant morbidity such as suicidal ideation and suicide attempts. This suggests that health-care providers should carefully screen for BDD, especially given that individuals with BDD tend to be ashamed of their BDD and may be reluctant to talk about their appearance concerns. Indeed, Grant et al. (2001) noted that none of the BDD inpatients in their study discussed specific BDD concerns with their physicians unless their physicians had directly queried them about appearance concerns. Further, it is important to develop specific screening instruments for BDD that can be easily used in various settings such as primary care, dermatology, plastic/cosmetic surgery and psychiatry. Moreover, given that BDD, relative to other psychiatric disorders, is still a relatively unknown disorder, which has only just recently started to receive attention from the media, it is possible that there are many individuals with BDD who are unaware that they suffer from it and unaware that it can be successfully treated with psychotropic medication (see Phillips et al., 2006) and cognitive-behavioural therapy (e.g., Rosen et al., 1995, Wilhelm et al., 1999). The establishment of reliable BDD prevalence rates could enable us to better estimate the treatment needs for these individuals, and to begin to disseminate effective treatments to the general public and health-care providers in particular.
Moreover, our survey confirmed that many people in the general population have subclinical concerns about some aspects of their appearance. Specifically, females were mostly concerned about their stomach, hips/buttocks, weight and breasts, whereas males were mostly concerned about their stomach and weight.
Our study has several limitations. Although BDD was assessed using classification rules very similar to the DSM-IV, our findings are based on self-report data, rather than clinician-administered structured interviews. However, given that BDD sufferers are often ashamed and might not even reveal their specific BDD concerns to their physicians unless specifically asked (Grant et al., 2001), it is possible that they are more willing to disclose their concerns in a survey than they are in an in-person interview. Given that individuals with BDD are often characterised by a lack of insight (e.g., Eisen et al., 2004), it is possible that some of our respondents had BDD but failed to recognise it. If so, the prevalence of 1.8% obtained in the current study may underestimate the true prevalence of BDD. For example, we asked our participants whether they were preoccupied with some aspects of their appearance although other people did not share their opinion. Thus, a BDD sufferer with a lack of insight is likely to think that he/she has a real defect which other people notice as well, and may not answer this question with “Yes” due to his/her delusional thinking. This may also partly explain why some individuals in the non-BDD group reported suicidal thoughts (3.5%) and even suicide attempts (2.1%) due to their appearance concerns (although, as expected, the non-BDD group endorsed those questions significantly less often than did the BDD group, P<.002). Another limitation of the present study is the lack of an assessment of co-morbid psychiatric disorders such as depression or anxiety disorders. An assessment of co-morbid depression and/or depressive symptoms, for example, could have allowed us to examine why we obtained a much higher rate of suicide attempts in our current study, relative to the rate obtained by Rief et al. (2006). Further, it should be noted that – on the one hand – a more detailed assessment is needed for a differential diagnosis of an eating disorder. However, given that the focus of this study was to assess the prevalence of BDD, the additional screening questions for eating disorder symptoms were only used for the purpose of not misdiagnosing individuals with eating disorders as having BDD. On the other hand, excluding individuals with a primary weight preoccupation may have led to a possible underestimation of the current BDD prevalence. In addition, it would be interesting to examine the influence of age on BDD symptoms in future general population studies.
In sum, to our knowledge, this is one of the first studies investigating the prevalence of BDD using a representative nation-wide sample of the general population. Our obtained BDD prevalence of 1.8% is remarkably consistent with our previously obtained prevalence of 1.7% (Rief et al., 2006) and comparable to the BDD prevalence of 2.4% in the U.S. population (Koran et al., 2008). Moreover, our findings provide additional evidence that BDD is associated with significant distress and morbidity and further emphasise the need for continued research on this chronic and severe disorder.

Footnote

1
We acknowledge that a more detailed assessment is needed for a differential diagnosis of an eating disorder. It should be noted though that the focus of this study was to assess the prevalence of BDD and that the additional screening questions for eating disorder symptoms were only used for the purpose of not misdiagnosing individuals with eating disorders as having BDD. It should be noted though that the exclusion of primary weight concerns could have led to an underestimation of the BDD prevalence.

References

American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders– Text Revision, (4th ed.). Author, Washington, DC.
Biby, E.L., 1998. The relationship between body dysmorphic disorder and depression, self- esteem, somatization, and obsessive–compulsive disorder. Journal of Clinical Psychology 54, 489–499.
Bienvenu, O.J., Samuels, J.F., Ridde, M.A., Hoehn-Saric, R., Liang, K.-Y., Cullen, B.A.M., Grados, M.A., Nestadt, G., 2000. The relationship of obsessive–compulsive disorder to possible spectrum disorders: results from a family study. Biological Psychiatry 48, 287–293.
Bohne, A., Wilhelm, S., Keuthen, N.J., Florin, I., Baer, L., Jenike, M.A., 2002. Prevalence of body dysmorphic disorder in a German college student sample. Psychiatry Research 109, 101–104.
Cansever, A., Uzun, Ö., Dönmez, E., Ozsahin, A., 2003. The prevalence and clinical features of body dysmorphic disorder in college students: a study in a Turkish sample. Comprehensive Psychiatry 44, 60–64.
Eisen, J.L., Phillips, K.A., Coles, M.E., Rasmussen, S.A., 2004. Insight in obsessive compulsive disorder and body dysmorphic disorder. Comprehensive Psychiatry 45, 10–15.
Faravelli, C., Salvatori, S., Galassi, F., Aiazzi, L., Drei, C., Cabras, P., 1997. Epidemiology of somatoform disorders: a community survey in Florence. Social Psychiatry and Psychiatric Epidemiology 32, 24–29.
Grant, J.E., Kim, S.W., Crow, S.J., 2001. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. Journal of Clinical Psychiatry 62, 517–522.
Koran, L.M., Abujaoude, E., Large, M.D., Serpe, R.T., 2008. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectrums 13, 1–7.
Otto, M., Wilhelm, S., Cohen, L.S., Harlow, B.L., 2001. Prevalence of body dysmorphic disorder in a community sample of women. American Journal of Psychiatry 158, 2061–2063.
Phillips, K.A., 1991. Body dysmorphic disorder: the distress of imagined ugliness. American Journal of Psychiatry 148, 1138–1149.
Phillips, K.A., 2000. Quality of life for patients with body dysmorphic disorder. The Journal of Nervous and Mental Disease 188, 170–175.
Phillips, K.A., Menard, W., 2006. Suicidality in body dysmorphic disorder: a prospective study. American Journal of Psychiatry 163, 1280–1282.
Phillips, K.A., McElroy, S.L., Keck, P.E., Pope, H.G., Hudson, J.I., 1993. Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry 150, 302–308.
Phillips, K.A., Pagano, M.E., Menare, W., 2006. Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity. Annals of Clinical Psychiatry 18, 251–257.
Rief, W., Hessel, A., Brähler, E., 2001. Somatization symptoms and hypochondriacal features in the general population. Psychosomatic Medicine 63, 595–602.
Rief, W., Buhlmann, U., Wilhelm, S., Borkenhagen, A., Brähler, E., 2006. The prevalence of body dysmorphic disorder: a population-based survey. Psychological Medicine 36, 877–885.
Rosen, J.C., Reiter, J., Orosan, P., 1995. Cognitive–behavioral body image therapy for body dysmorphic disorder. Journal of Consulting and Clinical Psychology 63, 263–269.
Wilhelm, S., Otto, M.W., Lohr, B., Deckersbach, T., 1999. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behaviour Research and Therapy 37, 71–75.

Information & Authors

Information

Published In

History

Published in print: Spring 2015
Published online: 15 April 2015

Authors

Details

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share